Mara Dierssen

<i>Dyrk1A</i> Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice

Vassiliki Fotaki, Mara Dierssen, Soledad Alcántara et al. · Molecular and Cellular Biology · 2002 · 341 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes

Isabel del Pino, Cristina Garcı́a-Frigola, Nathalie Dehorter et al. · Neuron · 2013 · 330 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Rafael de la Torre, Susana Solá, Gimena Hernández et al. · The Lancet Neurology · 2016 · 286 citations

Medicine, Neurology, Neuroscience +9

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in <scp>D</scp>own syndrome mouse models and in humans

Rafael de la Torre, Susana Solá, Meritxell Pons‐Espinal et al. · Molecular Nutrition & Food Research · 2013 · 279 citations

Life Sciences, Genetics, Neuroscience +17

Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway

Berta Vidal, Antonio L. Serrano, Marc Tjwa et al. · Genes & Development · 2008 · 255 citations · Full text

Veterinary Medicine, Molecular Biology, Pathobiology +17